During the past decade, Omega Research Maitland, LLC conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Omega Research Maitland, LLC" #1 sponsor was "Celgene" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Calliditas Therapeutics AB" with 1 trials sponsored, "Cyclerion Therapeutics" with 1 trials sponsored and "Equillium" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Omega Research Maitland, LLC" #1 collaborator was "Biocon Limited" with 1 trials as a collaborator, "Mylan GmbH" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Omega Research Maitland, LLC" are "Crohn Disease" (3 trials), "Lupus Nephritis" (2 trials), "Systemic Lupus Erythematosus" (2 trials), "Clostridium Difficile Infection" (1 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "Omega Research Maitland, LLC" in a lesser frequency.

Most popular intervention types in "Omega Research Maitland, LLC" are "Drug" (14 trials), "Other" (2 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Ozanimod" (3 trials), "Cenicriviroc" (1 trials), "FlexPen NovoLog®" (1 trials) and "IW-1701" (1 trials). Other intervention names were less common.

The vast majority of trials in "Omega Research Maitland, LLC" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Omega Research Maitland, LLC". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Omega Research Maitland, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Omega Research Maitland, LLC, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".